FTIOP
JAZZ icon

Fiduciary Trust International of Pennsylvania’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,725
Closed -$343K – 339
2013
Q3 		$343K Buy
+3,725
New +$300K 0.03% 256

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's JAZZ Position: Q4 2013 in Review

Fiduciary Trust International of Pennsylvania sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2013, closing a stake of 3,725 shares — an estimated $343K sold.

Fiduciary Trust International of Pennsylvania first reported a position in JAZZ in Q3 2013 and held it in 1 quarter. The position peaked at $343K in Q3 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

  • Fiduciary Trust International of Pennsylvania reported no remaining Jazz Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 3,725 Jazz Pharmaceuticals shares in Q4 2013, an estimated $343K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Fiduciary Trust International of Pennsylvania's Jazz Pharmaceuticals position peaked at $343K in Q3 2013.
  • 280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2013, filed 16 Jan 2014.